The Prevalence Of Cervical Regulatory T Cells in HPV-Related Cervical Intraepithelial Neoplasia (CIN) Correlates Inversely with Spontaneous Regression of CIN

American Journal of Reproductive Immunology

Volumn 69, Issue 2, 2013, Pages 134-141

  Kojima, Satoko ^a   Kawana, Kei ^a   Tomio, Kensuke ^a   Yamashita, Aki ^a   Taguchi, Ayumi ^a   Miura, Shiho ^a   Adachi, Katsuyuki ^a   Nagamatsu, Takeshi ^a   Nagasaka, Kazunori ^a   Matsumoto, Yoko ^a   Arimoto, Takahide ^a   Oda, Katsutoshi ^a   Wada Hiraike, Osamu ^a   Yano, Tetsu ^a   Taketani, Yuji ^a   Fujii, Tomoyuki ^a   Schust, Danny J ^b   Kozuma, Shiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b University of Missouri   (United States)

Author keywords

CD4+CD25+Foxp3+ regulatory T cells; Cervical intraepithelial neoplasia; Cervical lymphocytes; Programmed cell death 1

Indexed keywords

PROGRAMMED DEATH 1 RECEPTOR;

ARTICLE; CANCER REGRESSION; CD4+ T LYMPHOCYTE; CELL ISOLATION; CLINICAL ARTICLE; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; MENSTRUAL CYCLE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REMISSION; SMOKING; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS; COMPLICATION; IMMUNOLOGY; PAPILLOMAVIRUS INFECTION; PATHOLOGY; TUMOR REGRESSION; UTERINE CERVIX TUMOR; VIROLOGY;

CD4-POSITIVE T-LYMPHOCYTES; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; NEOPLASM REGRESSION, SPONTANEOUS; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 84872264062     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12030     Document Type: Article

References (34)

1. Holowaty P, Miller AB, Rohan T, To T: Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 1999; 91:252-258.
2. Moscicki AB, Schiffman M, Kjaer S, Villa LL: Chapter 5: updating the natural history of HPV and anogenital cancer. Vaccine 2006; 24:42-51.
3. Ellerbrock TV, Chiasson MA, Bush TJ, Sun XW, Sawo D, Brudney K, Wright TC Jr: Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 2000; 283:1031-1037.
4. Ognenovski VM, Marder W, Somers EC, Johnston CM, Farrehi JG, Selvaggi SM, McCune WJ: Increased incidence of cervical intraepithelial neoplasia in women with systemic lupus erythematosus treated with intravenous cyclophosphamide. J Rheumatol 2004; 31:1763-1767.
5. Kojima S, Kawanna K, Fujii T, Yokoyama T, Miura S, Tomio K, Tomio A, Yamashita A, Adachi K, Sato H, Nagamatsu T, Schust DJ, Kozuma S, Taketani Y: Characterization of Gut-Derived Intraepithelial Lymphocyte (IEL) Residing in Human Papillomavirus (HPV)-Infected Intraepithelial Neoplastic Lesions. Am J Reprod Immunol 2011; 66:435-443.
6. Wolf D, Wolf AM, Rumpold H, Fiegl H, Zeimet AG, Muller-Holzner E, Deibl M, Gastl G, Gunsilius E, Marth C: The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. Clin Cancer Res 2005; 11:8326-8331.
7. Jordanova ES, Gorter A, Ayachi O, Prins F, Durrant LG, Kenter GG, van der Burg SH, Fleuren GJ: Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients? Clin Cancer Res 2008; 14:2028-2035.
8. Yamagami W, Susumu N, Tanaka H, Hirasawa A, Banno K, Suzuki N, Tsuda H, Tsukazaki K, Aoki D: Immunofluorescence-detected infiltration of CD4+FOXP3+ regulatory T cells is relevant to the prognosis of patients with endometrial cancer. Int J Gynecol Cancer 2011; 21:1628-1634.
9. Koyama K, Kagamu H, Miura S, Hiura T, Miyabayashi T, Itoh R, Kuriyama H, Tanaka H, Tanaka J, Yoshizawa H, Nakata K, Gejyo F: Reciprocal CD4+ T-cell balance of effector CD62Llow CD4+ and CD62LhighCD25+ CD4+ regulatory T cells in small cell lung cancer reflects disease stage. Clin Cancer Res 2008; 14:6770-6779.
10. Liu F, Lang R, Zhao J, Zhang X, Pringle GA, Fan Y, Yin D, Gu F, Yao Z, Fu L: CD8; cytotoxic T cell and FOXP3; regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes. Breast Cancer Res Treat 2011; 130:645-655.
11. Yamamoto T, Yanagimoto H, Satoi S, Toyokawa H, Hirooka S, Yamaki S, Yui R, Yamao J, Kim S, Kwon AH: Circulating CD4+CD25+ regulatory T cells in patients with pancreatic cancer. Pancreas 2012; 41:409-415.
12. Jacobs JF, Nierkens S, Figdor CG, de Vries IJ, Adema GJ: Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy? Lancet Oncol 2012; 13:32-42.
13. Liotta F, Gacci M, Frosali F, Querci V, Vittori G, Lapini A, Santarlasci V, Serni S, Cosmi L, Maggi L, Angeli R, Mazzinghi B, Romagnani P, Maggi E, Carini M, Romagnani S, Annunziato F: Frequency of regulatory T cells in peripheral blood and in tumour-infiltrating lymphocytes correlates with poor prognosis in renal cell carcinoma. BJU Int, 2011; 107:1500-1506.
14. Fu J, Xu D, Liu Z, Shi M, Zhao P, Fu B, Zhang Z, Yang H, Zhang H, Zhou C, Yao J, Jin L, Wang H, Yang Y, Fu YX, Wang FS: Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology 2007; 132:2328-2339.
15. French JD, Weber ZJ, Fretwell DL, Said S, Klopper JP, Haugen BR: Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer. J Clin Endocrinol Metab 2010; 95:2325-2333.
16. Francisco LM, Sage PT, Sharpe AH: The PD-1 pathway in tolerance and autoimmunity. Immunol Rev 2010; 236:219-242.
17. Maria A, Lafaille C, Lafaille JJ: Natural and adaptive Foxp3+ regulatory T cells: more of the same or a division of labor? Immunity 2009; 30:626-635.
18. Driessens G, Kline J, Gajewski TF: Costimulatory and coinhibitory receptors in anti-tumor immunity. Immunol Rev 2009; 229:126-144.
19. Visser J, Nijman HW, Hoogenboom BN, Jager P, van Baarle D, Schuuring E, Abdulahad W, Miedema F, van der Zee AG, Daemen T: Frequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia. Clin Exp Immunol 2007; 150:199-209.
20. Molling JW, de Gruijl TD, Glim J, Moreno M, Rozendaal L, Meijer CJ, van den Eertwegh AJ, Scheper RJ, von Blomberg ME, Bontkes HJ: CD4(+)CD25hi regulatory T-cell frequency correlates with persistence of human papillomavirus type 16 and T helper cell responses in patients with cervical intraepithelial neoplasia. Int J Cancer 2007; 121:1749-1755.
21. Nakamura T, Shima T, Saeki A, Hidaka T, Nakashima A, Takikawa O, Saito S: Expression of indoleamine 2, 3-dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer. Cancer Sci 2007; 98:874-881.
22. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hildesheim A, Schiffman MH, Scott DR, Apple RJ: Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000; 38:357-361.
23. Bosch FX, Sanjose S: Human papillomavirus and cervical cancer - burden and assessment of causality. J Natl Cancer Inst Monogr 2003; 31:3-13.
24. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA: CD4+CD25high regulatory cells in human peripheral blood. J Immunol 2001; 167:1245-1253.
25. Shen T, Zheng J, Liang H, Xu C, Chen X, Zhang T, Xu Q, Lu F: Characteristics and PD-1 expression of peripheral CD4+CD127loCD25hiFoxP3+ Treg cells in chronic HCV infected-patients. Virol J 2011; 8:279-287.
26. zur Hausen H: Papillomavirus and cancer: from basic studies to clinical application. Nat Rev Cancer 2002; 2:342-350.
27. Scott ME, Ma Y, Kuzmich L, Moscicki AB: Diminished IFN-gamma and IL-10 and elevated Foxp3 mRNA expression in the cervix are associated with CIN 2 or 3. Int J Cancer 2009; 124:1379-1383.
28. El-Sherif AM, Seth R, Tighe PJ, Jenkins D: Decreased synthesis and expression of TGF-beta1, beta2, and beta3 in epithelium of HPV 16-positive cervical precancer: a study by microdissection, quantitative RT-PCR, and immunocytochemistry. J Pathol 2000; 192:494-501.
29. Xu XC, Mitchell MF, Silva E, Jetten A, Lotan R: Decreased expression of retinoic acid receptors, transforming growth factor beta, involucrin, and cornifin in cervical intraepithelial neoplasia. Clin Cancer Res 1999; 5:1503-1508.
30. Arruvito L, Sanz M, Banham AH, Fainboim L: Expansion of CD4+CD25+ and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction. J Immunol 2007; 178:2572-2578.
31. Weinberg A, Enomoto L, Marcus R, Canniff J: Effect of menstrual cycle variation in female sex hormones on cellular immunity and regulation. J Reprod Immunol 2011; 89:70-77.
32. Brandsma CA, Hylkema MN, Geerlings M, van Geffen WH, Postma DS, Timens W, Kerstjens HA: Increased levels of (class switched) memory B cells in peripheral blood of current smokers. Respir Res 2009; 10:108.
33. Barceló B, Pons J, Ferrer JM, Sauleda J, Fuster A, Agustí AG: Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking. Eur Respir J 2008; 31:555-562.
34. Vargas-Rojas MI, Ramírez-Venegas A, Limón-Camacho L, Ochoa L, Hernández-Zenteno R, Sansores RH: Increase of Th17 cells in peripheral blood of patients with chronic obstructive pulmonary disease. Respir Med 2011; 105:1648-1654.